Photocure: New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Press release - Oslo, Norway, March 28, 2024: Photocure ASA, The Bladder Cancer Company, announces the publication of the study Racial Difference in Detection Rate of Bladder Cancer Using Blue Light.
New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Photocure Partner Asieris Presented Clinical Trial and Real-World Data on Hexvix in China at ASCO GU 2024 urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 88.9 million in the second quarter of 2021 (Q2 2020: NOK 53.5), and.